What Is Renal Medullary Carcinoma?
More Programs and Publications Featuring Dr. Pavlos Msaouel
In this program:
What is renal medullary carcinoma (RMC)? Dr. Pavlos Msaouel, a medical oncologist treating rare forms of renal cell and urothelial carcinomas, gives an overview of RMC, a rare, deadly type of kidney cancer predominantly afflicting young adults of African descent with sickle cell disease. Watch as Dr. Msaouel shares what symptoms have often led to diagnosis and points out that 75 percent of all RMC cases originate in the right kidney.
Read Transcript
Rebecca:
Dr. Msaouel, what is renal medullary carcinoma and how is it diagnosed?
Dr. Pavlos Msaouel:
RMC is the acronym for a kidney cancer named renal medullary carcinoma. Renal medullary carcinoma or RMC is one of the deadliest kidney cancers, and it predominantly afflicts young people mainly of African descent that carry the sickle cell trait or sickle cell disease.
It is often diagnosed after patients start developing symptoms, and those symptoms can be blood in the urine -- the medical term is hematuria -- or they may have pain in their flanks on their side where the kidneys would be, on the right side or on the left side.
Interestingly RMC mainly happens on the right kidney, so about 75 percent of all RMC cases will happen in the right kidney. And unfortunately, in the vast majority of cases when it does present, it will be what we call stage 4 -- meaning metastatic -- meaning it will have spread to other organs.
In retaining editorial control, the information produced by Diverse Health Hub does not encapsulate the views of our sponsors, contributors, or collaborators.
Importantly, this information is not a substitute for, nor does it replace professional medical advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a healthcare professional. To learn more about privacy, read our Privacy Policy.
